- It is hoped that the proposed treatment method will slow down the progression of the disease and improve the quality of life of MS patients," says Adam Stępień, head of the Neurology Clinic at the Military Medical Institute, the principal investigator in the PROTECT-MS study, which is evaluating the effectiveness of using probiotics of the genus Lactobacillus in the treatment of multiple sclerosis. The PLN 17 million project will be funded by the Medical Research Agency.
The research team, whose work will be coordinated by Prof. Adam Stępień, M.D., Ph. Wojciech Szypowski, MD, and Dr. Marcin Pękalski, has developed a therapy of daily oral administration of live probiotic drugs from the genus Lactobacillus in combination with already used standard therapy with immunomodulatory drugs. The 6-year PROTECT-MS project will test the effect of this therapy on clinical and radiological features of multiple sclerosis (MS) activity.
As part o...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
